E-LIB Suche - Ergebnisse für: Cappellini, M. Domenica

1

Αlpha-thalassemia: A practical overview:

Musallam, Khaled M. ; Cappellini, M. Domenica ; Coates, Thomas D....
Blood Reviews. 64 (2024) - p. 101165 , 2024

Link: https://doi.org/10.1016/..

2

Oral ferroportin inhibitor vamifeport for improving iron ho..:

Porter, John ; Taher, Ali ; Viprakasit, Vip...
Expert Review of Hematology. 14 (2021) 7 - p. 633-644 , 2021

Link: https://doi.org/10.1080/..

3

Hematologic malignancies in thalassemia: Adding new cases t..:

Halawi, Racha ; Beydoun, Hassan ; Cappellini, M. Domenica..
American Journal of Hematology. 92 (2017) 5 - p. , 2017

Link: https://doi.org/10.1002/..

4

Optimising iron chelation therapy with deferasirox for non-..:

Taher, Ali T. ; Cappellini, M. Domenica ; Aydinok, Yesim...
Blood Cells, Molecules, and Diseases. 57 (2016) - p. 23-29 , 2016

Link: https://doi.org/10.1016/..

5

Development of a new disease severity scoring system for pa..:

Cappellini, M. Domenica ; Porter, John B. ; Musallam, Khaled M....
European Journal of Internal Medicine. 28 (2016) - p. 91-96 , 2016

Link: https://doi.org/10.1016/..

6

New insights into transfusion-related iron toxicity: Implic..:

Porter, John B. ; de Witte, Theo ; Cappellini, M. Domenica.
Critical Reviews in Oncology/Hematology. 99 (2016) - p. 261-271 , 2016

Link: https://doi.org/10.1016/..

7

Approaching low liver iron burden in chelated patients with..:

Taher, Ali T. ; Porter, John B. ; Viprakasit, Vip...
European Journal of Haematology. 92 (2014) 6 - p. 521-526 , 2014

Link: https://doi.org/10.1111/..

8

Deferasirox effectively reduces iron overload in non-transf..:

Taher, Ali T. ; Porter, John B. ; Viprakasit, Vip...
Annals of Hematology. 92 (2013) 11 - p. 1485-1493 , 2013

Link: https://doi.org/10.1007/..

9

Deferasirox demonstrates a dose‐dependent reduction in live..:

Taher, Ali T. ; Porter, John B. ; Viprakasit, Vip...
American Journal of Hematology. 88 (2013) 6 - p. 503-506 , 2013

Link: https://doi.org/10.1002/..

10

Treating iron overload in patients with non‐transfusion‐dep..:

Taher, Ali T. ; Viprakasit, Vip ; Musallam, Khaled M..
American Journal of Hematology. 88 (2013) 5 - p. 409-415 , 2013

Link: https://doi.org/10.1002/..

11

Improvement in Liver Pathology of Patients With β-Thalassem..:

Deugnier, Yves ; Turlin, Bruno ; Ropert, Martine...
Gastroenterology. 141 (2011) 4 - p. 1202-1211.e3 , 2011

Link: https://doi.org/10.1053/..

12

Redefining thalassemia as a hypercoagulable state:

Cappellini, M. Domenica ; Motta, Irene ; Musallam, Khaled M..
Annals of the New York Academy of Sciences. 1202 (2010) 1 - p. 231-236 , 2010

Link: https://doi.org/10.1111/..

13

Cholelithiasis in thalassemia major:

Origa, Raffaella ; Galanello, Renzo ; Perseu, Lucia...
European Journal of Haematology. 82 (2008) 1 - p. 22-25 , 2008

Link: https://doi.org/10.1111/..

14

cDNA Cloning and Functional Characterization of the Mouse C..:

Vandorpe, David H. ; Shmukler, Boris E. ; Jiang, Lianwei...
Journal of Biological Chemistry. 273 (1998) 34 - p. 21542-21553 , 1998

Link: https://doi.org/10.1074/..

15

A phase 3 trial of luspatercept in patients with transfusio..:

Domenica Cappellini M ; Viprakasit V ; Taher A.T...
10.1056/NEJMoa1910182. , 2020

Link: https://hdl.handle.net/1..